Home › NCT03617939

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer (ORIEN)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. 18 years of age and older.
2. Diagnosed with cancer, or may be at risk for cancer.
3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through a legally authorized representative (LAR).

Non-English speaking subjects will also be invited to participate in the TCCP study, in accordance with COMIRB's short-form consent use.

Exclusion Criteria:

1\. Members of vulnerable populations including neonates (birth to 30 days), children (under age 18), wards of the State, prisoners or those on probation or alternate sentencing, or decisionally challenged (adults or children that are cognitively impaired, incompetent to consent, proxy consent, or consenting in life threatening situations).

About the study

This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.

What is being tested

• Biospeciman Collection (procedure)
• Survey Assessments (other)
• Medical Chart Reviews (other)

Sponsor: University of Colorado, Denver · Participants: 20,000 · Started: Sep 16, 2015

Contact the study team

• Kyra Anderson · Phone: 303-724-3868

Official record on ClinicalTrials.gov — NCT03617939

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.